Page last updated: 2024-08-23

cefoperazone and Liver Neoplasms

cefoperazone has been researched along with Liver Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, QJ; Yu, ZP; Zeng, QQ; Zhang, QY; Zheng, XW1
Choe, KJ; Gottesman, MM; Hong, IG; Kim, HS; Kim, WH; Kim, YI; Lee, SK; Lim, KH; Park, JG; Tsuruo, T1

Other Studies

2 other study(ies) available for cefoperazone and Liver Neoplasms

ArticleYear
Primary hepatic actinomycosis mimicking liver tumour.
    ANZ journal of surgery, 2018, Volume: 88, Issue:7-8

    Topics: Actinomyces; Actinomycosis; Adult; Anti-Bacterial Agents; Cefoperazone; Diagnosis, Differential; Humans; Liver Diseases; Liver Neoplasms; Male; Tomography, X-Ray Computed; Treatment Outcome

2018
MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.
    Journal of the National Cancer Institute, 1994, May-04, Volume: 86, Issue:9

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Carrier Proteins; Cefoperazone; Ceftriaxone; Doxorubicin; Drug Resistance; Drug Synergism; Gene Expression; Humans; Immunohistochemistry; Liver Neoplasms; Membrane Glycoproteins; Neoplasm Proteins; Quinidine; RNA, Messenger; Trifluoperazine; Tumor Cells, Cultured; Verapamil

1994